Skip to main content
Clinical Trials/NCT02087020
NCT02087020
Completed
Not Applicable

Debridement, Antibiotics and Implant Retention in Early Periprosthetic Joint Infection: A Retrospective Cohort Study

Danderyd Hospital1 site in 1 country51 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Direct Infection of Hip- and Knee Arthroplasty
Sponsor
Danderyd Hospital
Enrollment
51
Locations
1
Primary Endpoint
Successful treatment
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Introduction: Periprosthetic joint infection (PJI) is a common cause for reoperation after knee and hip arthroplasty surgery. Debridement, antibiotics and implant retention (DAIR) is recommended in early infections (< 4 weeks) and stable implants. Aims: To define the success rate of DAIR in early infections and to identify predictors for success. Material and methods: In a retrospective cohort study we included patients with hip- or knee arthroplasties reoperated for an early PJI at Danderyd Hospital 2007-2012. Logistic regression analysis was used to identify risk factors affecting success rate. Primary outcome variable was the success of the DAIR treatment. Secondary outcome variable vas risk factors for treatment failure.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Danderyd Hospital
Responsible Party
Principal Investigator
Principal Investigator

Olof Skoldenberg

MD, PhD

Danderyd Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients treated with DAIR for early postoperative periprosthetic joint infection after knee- or hip arthroplasty surgery (\<4-6 weeks postoperatively) at our institution between 2007-01-01 and 2012-12-01.

Exclusion Criteria

  • Chronic or late presenting periprosthetic joint infection (\>6 weeks postoperatively), acute hematogenous periprosthetic joint infection, when the periprosthetic joint infection diagnosis criteria according to American Musculoskeletal Infection Society (MSIS) 2011 definition of PJI definitions were not fulfilled and when the initial surgical treatment was with other treatment protocol than DAIR including one-stage revision and two -stage revision

Outcomes

Primary Outcomes

Successful treatment

Time Frame: 6 year

The success rate, in terms of infection eradication without additional surgical methods, of debridement, antibiotics and implant retention in early postoperative periprosthetic joint infection..

Secondary Outcomes

  • Risk factors for treatment failure(6 year)

Study Sites (1)

Loading locations...

Similar Trials